The Anmat Authorized the over-the-Counter Sale of Ten Prescription-only Medicines
19 Articles
19 Articles
The measure reaches oral, ophthalmic and topical administration products that have been on the market for at least five years without reports of serious adverse effects that alter their balance between risks and benefits
The decision of the Anmat reaches active principles used to treat allergies, digestive disorders, dizziness, colds, dermatological conditions and other diseases of low complexity. The Government maintains that the decision seeks to expand access and favor a decrease in prices. They add to a long list of remedies that are no longer sold under prescription.
Canal C Drug-free sales: the warning of pharmacists The president of the Colegio de Farmacéuticos de Córdoba, Germán Daniele, analyzed in What is happening through Canal C the decision of ANMAT to enable the free sale of ten medicines.Although he clarified that they will continue to be marketed in pharmacies, he expressed his concern about a possible deregulation that allows to sell them outside these establishments and warned about the loss of …
The measure seeks to facilitate access to medicines of proven safety, quality and efficacy, while promoting their responsible use.
By means of provision 4714/2026 published in the Official Gazette, the National Administration of Medicines, Food and Medical Technology (ANMAT) authorized the over-the-counter sale of ten groups of medicinal products, with the aim of facilitating access to these products and promoting their responsible use. The measure reaches products that accredited at least five years of marketing without serious adverse events affecting the risk-benefit bal…
By Order No. 4714/2026, the National Administration of Medicines, Food and Medical Technology (ANMAT) established the condition of over-the-counter sale for all medicinal specialties registered in the Registry of Medicinal Specialties (REM) containing ten active pharmaceutical ingredients (IFA) intended for the treatment of low-complex conditions. The measure seeks to facilitate access to medicines of proven safety, quality and efficacy, while p…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
